IRIS Accounts Production v24.2.0.383 14418684 Board of Directors 14.10.22 31.3.24 31.3.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh144186842022-10-13144186842024-03-31144186842022-10-142024-03-31144186842022-10-1314418684ns15:EnglandWales2022-10-142024-03-3114418684ns14:PoundSterling2022-10-142024-03-3114418684ns10:Director12022-10-142024-03-3114418684ns10:PrivateLimitedCompanyLtd2022-10-142024-03-3114418684ns10:SmallEntities2022-10-142024-03-3114418684ns10:AuditExemptWithAccountantsReport2022-10-142024-03-3114418684ns10:SmallCompaniesRegimeForDirectorsReport2022-10-142024-03-3114418684ns10:SmallCompaniesRegimeForAccounts2022-10-142024-03-3114418684ns10:FullAccounts2022-10-142024-03-311441868412022-10-142024-03-3114418684ns10:Director22022-10-142024-03-3114418684ns10:RegisteredOffice2022-10-142024-03-3114418684ns5:CurrentFinancialInstruments2024-03-3114418684ns5:ShareCapital2024-03-3114418684ns5:RetainedEarningsAccumulatedLosses2024-03-3114418684ns5:NetGoodwill2022-10-142024-03-3114418684ns5:IntangibleAssetsOtherThanGoodwill2022-10-142024-03-3114418684ns5:FurnitureFittings2022-10-142024-03-3114418684ns5:MotorVehicles2022-10-142024-03-3114418684ns5:ComputerEquipment2022-10-142024-03-3114418684ns5:NetGoodwill2024-03-3114418684ns5:FurnitureFittings2024-03-3114418684ns5:MotorVehicles2024-03-3114418684ns5:ComputerEquipment2024-03-3114418684ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3114418684ns5:DeferredTaxation2024-03-31144186841ns10:Director12022-10-13144186841ns10:Director12022-10-142024-03-31144186841ns10:Director12024-03-3114418684ns10:Director222022-10-1314418684ns10:Director222022-10-142024-03-3114418684ns10:Director222024-03-31
REGISTERED NUMBER: 14418684 (England and Wales)

















Unaudited Financial Statements

for the Period

14 October 2022 to 31 March 2024

for

Pharmacy Plus Limited

Pharmacy Plus Limited (Registered number: 14418684)






Contents of the Financial Statements
for the Period 14 October 2022 to 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

Pharmacy Plus Limited

Company Information
for the Period 14 October 2022 to 31 March 2024







DIRECTORS: Mr A Hossain
Mr S R Rahman





REGISTERED OFFICE: 48 Lindsay Avenue
Manchester
Greater Manchester
M19 2AG





REGISTERED NUMBER: 14418684 (England and Wales)





ACCOUNTANTS: Sterling Partners Limited
Chartered Accountants
Chartered Tax Advisors
2nd Floor, Grove House
774-780 Wilmslow Road
Didsbury
Manchester
Greater Manchester
M20 2DR

Pharmacy Plus Limited (Registered number: 14418684)

Balance Sheet
31 March 2024

Notes £   
FIXED ASSETS
Intangible assets 4 150,930
Tangible assets 5 51,508
202,438

CURRENT ASSETS
Stocks 28,638
Debtors 6 114,057
Cash at bank and in hand 252,693
395,388
CREDITORS
Amounts falling due within one year 7 (434,077 )
NET CURRENT LIABILITIES (38,689 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

163,749

PROVISIONS FOR LIABILITIES 8 (932 )
NET ASSETS 162,817

CAPITAL AND RESERVES
Called up share capital 100
Retained earnings 162,717
162,817

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Pharmacy Plus Limited (Registered number: 14418684)

Balance Sheet - continued
31 March 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 10 September 2024 and were signed on its behalf by:





Mr A Hossain - Director


Pharmacy Plus Limited (Registered number: 14418684)

Notes to the Financial Statements
for the Period 14 October 2022 to 31 March 2024

1. STATUTORY INFORMATION

Pharmacy Plus Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Goodwill
Goodwill, being the amount paid in connection with the acquisition of a business in 2022, is being amortised evenly over its estimated useful life of ten years.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Fixtures and fittings - 20% on reducing balance
Motor vehicles - 20% on reducing balance
Computer equipment - 20% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.


Pharmacy Plus Limited (Registered number: 14418684)

Notes to the Financial Statements - continued
for the Period 14 October 2022 to 31 March 2024

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 7 .

4. INTANGIBLE FIXED ASSETS
Goodwill
£   
COST
Additions 167,700
At 31 March 2024 167,700
AMORTISATION
Amortisation for period 16,770
At 31 March 2024 16,770
NET BOOK VALUE
At 31 March 2024 150,930

Pharmacy Plus Limited (Registered number: 14418684)

Notes to the Financial Statements - continued
for the Period 14 October 2022 to 31 March 2024

5. TANGIBLE FIXED ASSETS
Fixtures
and Motor Computer
fittings vehicles equipment Totals
£    £    £    £   
COST
Additions 6,045 56,167 2,173 64,385
At 31 March 2024 6,045 56,167 2,173 64,385
DEPRECIATION
Charge for period 1,209 11,233 435 12,877
At 31 March 2024 1,209 11,233 435 12,877
NET BOOK VALUE
At 31 March 2024 4,836 44,934 1,738 51,508

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 103,273
VAT 9,882
Prepayments 902
114,057

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade creditors 107,668
Tax 45,978
Social security and other taxes 551
Pension Payable 343
Wages payable 4,833
Other creditors 143,825
Directors' current accounts 130,499
Accrued expenses 380
434,077

8. PROVISIONS FOR LIABILITIES
£   
Deferred tax 932

Deferred
tax
£   
Deferred tax on capital assets 932
Balance at 31 March 2024 932

Pharmacy Plus Limited (Registered number: 14418684)

Notes to the Financial Statements - continued
for the Period 14 October 2022 to 31 March 2024

9. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the period ended 31 March 2024:

£   
Mr A Hossain
Balance outstanding at start of period -
Amounts repaid (66,475 )
Amounts written off -
Amounts waived -
Balance outstanding at end of period (66,475 )

Mr S R Rahman
Balance outstanding at start of period -
Amounts repaid (64,025 )
Amounts written off -
Amounts waived -
Balance outstanding at end of period (64,025 )

Chartered Accountants' Report to the Board of Directors
on the Unaudited Financial Statements of
Pharmacy Plus Limited

The following reproduces the text of the report prepared for the directors in respect of the company's annual unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Pharmacy Plus Limited for the period ended 31 March 2024 which comprise the Income Statement, Balance Sheet and the related notes from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed within the ICAEW's regulations and guidance at http://www.icaew.com/en/membership/regulations-standards-and-guidance.

This report is made solely to the Board of Directors of Pharmacy Plus Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of Pharmacy Plus Limited and state those matters that we have agreed to state to the Board of Directors of Pharmacy Plus Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Pharmacy Plus Limited and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that Pharmacy Plus Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of Pharmacy Plus Limited. You consider that Pharmacy Plus Limited is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the financial statements of Pharmacy Plus Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






Sterling Partners Limited
Chartered Accountants
Chartered Tax Advisors
2nd Floor, Grove House
774-780 Wilmslow Road
Didsbury
Manchester
Greater Manchester
M20 2DR


Date: .............................................